Avanir Pharmaceuticals
A biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD4.8b (Public information from Dec 2014)
Aliso Viejo California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
$16.2m | Growth Equity VC | ||
$30.0m | Debt | ||
$3.5b Valuation: $3.5b | Acquisition | ||
| Total Funding | CAD22.1m | ||
Related Content
Recent News about Avanir Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.